Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLU-PPV-S H5N1 influenza vaccine durability and cross-immunity study in healthy Japanese adults
jRCT1090220017Phase 4Completed
- Sponsor
- National Hospital Organization Mie National Hospital
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of attenuated H5N1 avian influenza virus vaccine in influenza (2 arms), sponsored by National Hospital Organization Mie National Hospital. Primary endpoints: Hemagglutination inhibition (HI) antibody titer against H5 antigen, Neutralizing antibody titer against H5N1 influenza virus and 1 more. Started Jul 2008; status: completed.
02
Drugs
attenuated H5N1 avian influenza virus vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT1090220017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220017.